Consensus Recommendations of the Asia Pacific Cardiometabolic Consortium on Secondary Prevention Strategies in Myocardial Infarction: Recommendations on Pharmacotherapy, Lifestyle Modification and Cardiac Rehabilitation

Secondary prevention of acute MI, both ST elevated and non-ST elevated is essential to reduce cardiovascular mortality and hospital readmission, ensuring patients return to normality with an improved quality of life. Thus far, professional associations and country-specific guidelines have provided guidance suited to their respective populations. The Asia Pacific Cardiometabolic Consortium has developed these consensus recommendations to unify the approach to long-term care of patients after MI, which can be applied across the Asia-Pacific region. The consensus statements, which were developed by an expert panel, took into account international and local guidelines and current evidence, along with the opinions and professional experience offered by regional experts. These statements were then put to an online vote to achieve a consensus. The resulting 13 statements discuss secondary prevention strategies encompassing pharmacotherapy, lifestyle modifications, cardiac rehabilitation and discharge management for the effective long-term care of patients with a history of type 1 MI, specifically relating to atherosclerotic plaque rupture and thrombosis.